Literature DB >> 12393745

Hypoxic up-regulation of erythroid 5-aminolevulinate synthase.

Thomas Hofer1, Roland H Wenger, Marianne F Kramer, Gloria C Ferreira, Max Gassmann.   

Abstract

The erythroid-specific isoform of 5-aminolevulinate synthase (ALAS2) catalyzes the rate-limiting step in heme biosynthesis. The hypoxia-inducible factor-1 (HIF-1) transcriptionally up-regulates erythropoietin, transferrin, and transferrin receptor, leading to increased erythropoiesis and hematopoietic iron supply. To test the hypothesis that ALAS2 expression might be regulated by a similar mechanism, we exposed murine erythroleukemia cells to hypoxia (1% O(2)) and found an up to 3-fold up-regulation of ALAS2 mRNA levels and an increase in cellular heme content. A fragment of the ALAS2 promoter ranging from -716 to +1 conveyed hypoxia responsiveness to a heterologous luciferase reporter gene construct in transiently transfected HeLa cells. In contrast, iron depletion, known to induce HIF-1 activity but inhibit ALAS2 translation, did not increase ALAS2 promoter activity. Mutation of a previously predicted HIF-1-binding site (-323/-318) within this promoter fragment and DNA-binding assays revealed that hypoxic up-regulation is independent of this putative HIF-1 DNA-binding site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393745     DOI: 10.1182/blood-2002-03-0773

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Ferrochelatase regulates retinal neovascularization.

Authors:  Sardar Pasha Sheik Pran Babu; Darcy White; Timothy W Corson
Journal:  FASEB J       Date:  2020-07-27       Impact factor: 5.191

2.  Induction of gastrin expression in gastrointestinal cells by hypoxia or cobalt is independent of hypoxia-inducible factor (HIF).

Authors:  Lin Xiao; Suzana Kovac; Mike Chang; Arthur Shulkes; Graham S Baldwin; Oneel Patel
Journal:  Endocrinology       Date:  2012-05-16       Impact factor: 4.736

Review 3.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

Review 4.  Hypoxic regulation of erythropoiesis and iron metabolism.

Authors:  Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-05

Review 5.  Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2017-05-05       Impact factor: 3.905

6.  Bifurcated BACH2 control coordinates mantle cell lymphoma survival and dispersal during hypoxia.

Authors:  Han Zhang; Zheng Chen; Roberto N Miranda; L Jeffrey Medeiros; Nami McCarty
Journal:  Blood       Date:  2017-06-07       Impact factor: 22.113

7.  Differences in the sensitivity of ovarian cancer to photodynamic therapy and the mechanisms for those differences.

Authors:  Yoshihito Yokoyama; Tatsuhiko Shigeto; Rie Miura; Asami Kobayashi; Makito Mizunuma; Aisa Yamauchi; Masayuki Futagami; Hideki Mizunuma
Journal:  Oncol Lett       Date:  2017-04-25       Impact factor: 2.967

8.  Protection of cardiomyocytes from ischemic/hypoxic cell death via Drbp1 and pMe2GlyDH in cardio-specific ARC transgenic mice.

Authors:  Jong-Ok Pyo; Jihoon Nah; Hyo-Jin Kim; Jae-Woong Chang; Young-Wha Song; Dong-Kwon Yang; Dong-Gyu Jo; Hyung-Ryong Kim; Han-Jung Chae; Soo-Wan Chae; Seung-Yong Hwang; Seung-Jun Kim; Hyo-Joon Kim; Chunghee Cho; Chang-Gyu Oh; Woo Jin Park; Yong-Keun Jung
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

9.  Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure.

Authors:  Yoji Andrew Minamishima; Javid Moslehi; Nabeel Bardeesy; Darragh Cullen; Roderick T Bronson; William G Kaelin
Journal:  Blood       Date:  2007-12-20       Impact factor: 22.113

Review 10.  Anaemia in kidney disease: harnessing hypoxia responses for therapy.

Authors:  Mark J Koury; Volker H Haase
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.